I think the two most newsworthy items would be the original ANDA getting approved (obvi) and the results of the Viagra study. If the results of the Viagra study are known, I'd say this week would be a hell of a time to release them with the volume we are starting to see. Builds momentum heading into the shareholder meeting as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.